Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer (Q43237571)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 October 2009
edit
Language Label Description Also known as
English
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer
scientific article published on 27 October 2009

    Statements

    Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer (English)
    0 references
    0 references
    Motoki Miyazawa
    Ryuji Ohsawa
    Takuya Tsunoda
    Seiko Hirono
    Manabu Kawai
    Masaji Tani
    Yusuke Nakamura
    Hiroki Yamaue
    27 October 2009
    433-439

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit